| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 541 |
| 1 | OLANZAPINE | 523 |
| 2 | RISPERIDONE | 513 |
| 3 | QUETIAPINE | 504 |
| 4 | OLANZAPINE PAMOATE | 483 |
| 5 | ZIPRASIDONE HYDROCHLORIDE | 421 |
| 6 | LURASIDONE HYDROCHLORIDE | 412 |
| 7 | CLOZAPINE | 410 |
| 8 | QUETIAPINE FUMARATE | 405 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 404 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE HCL | 359 | 0.1449 |
| 1 | ASENAPINE MALEATE | 398 | 0.0488 |
| 2 | FLUPHENAZINE DECANOATE | 12 | 0.0321 |
| 3 | ZIPRASIDONE HYDROCHLORIDE | 421 | 0.0238 |
| 4 | LURASIDONE HYDROCHLORIDE | 412 | 0.0216 |
| 5 | OLANZAPINE PAMOATE | 483 | 0.0124 |
| 6 | PALIPERIDONE PALMITATE | 269 | 0.0105 |
| 7 | OLANZAPINE | 523 | 0.0060 |
| 8 | ZIPRASIDONE MESYLATE | 79 | 0.0057 |
| 9 | CAMPHOR AND MENTHOL | 1 | 0.0056 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 646 |
| 1 | Typical Antipsychotic [EPC] | 36 |
| 2 | Mood Stabilizer [EPC] | 25 |
| 3 | Anti-epileptic Agent [EPC] | 24 |
| 4 | Benzodiazepine [EPC] | 17 |
| 5 | Corticosteroid [EPC] | 3 |
| 6 | Ergot Derivative [EPC] | 3 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 2 |
| 9 | Calcium Channel Blocker [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Typical Antipsychotic [EPC] | 36 | 0.0018 |
| 1 | Atypical Antipsychotic [EPC] | 646 | 0.0015 |
| 2 | Ergot Derivative [EPC] | 3 | 0.0008 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0002 |
| 4 | Melatonin Receptor Agonist [EPC] | 2 | 0.0002 |
| 5 | Mood Stabilizer [EPC] | 25 | 0.0001 |
| 6 | Anti-epileptic Agent [EPC] | 24 | 0.0001 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0001 |
| 8 | Phenothiazine [EPC] | 1 | 0.0000 |
| 9 | Insulin [EPC] | 2 | 0.0000 |